MB

Michael Baran

VC Partner, Partner - Pfizer Ventures

Location

United States, North America

Check Size

$100K - $15M

Investment Stage

Pre Seed
Seed
Series A
Series B

Focus Areas

BioTech
Pharmaceuticals

About Investor

Michael Baran is Executive Director, Worldwide Business Development & Partner at Pfizer Ventures in New York City. He leads equity investments in biotech startups from pre-seed through Series B, with checks ranging from $100 K to $15 million (sweet spot $10 million), and his most recent commitment is to Capstan Therapeutics. He is based in New York. Prior to venture investing, he co-founded Nexomics Biosciences, managed R&D portfolio strategy for Pfizer, and serves as an adjunct assistant professor at Stony Brook University.

Looking for investors like Michael Baran?
Get matched with the right ones for your startup.

Explore more investors

Previous investments

ImmunOs Therapeutics
11M |2024
73M |2022
15M |2019
Capstan Therapeutics
180M |2024
100M |2022
VitaDAO
4M |2023
500K |2022

Similar Investors

AL

Abdul Ly

United States, North America
$1M - $4M

Seed

,

Series A

,
PS

Paul Straub

United States, North America
$100K - $2M

Pre Seed

,

Seed

,
SA

Shaun Abrahamson

United States, North America
$250K - $1M

Pre Seed

,

Seed

,
RF

Riley Florsheim

United States, North America
$100K - $5M

Pre Seed

,

Seed

,
SB

Steve Brownlie

United States, North America
$250K - $1.4M

Pre Seed

,

Seed

,
DG

Danielle Graham

Canada, North America
$100K - $300K

Pre Seed

,

Seed

,

Is this You?

Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors

This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.

Start Matching For Free